Simponi (golimumab) has a half-life of about two weeks, meaning it takes roughly 10 to 12 weeks for the drug to fully clear your body after your last dose. However, the European Medicines Agency notes that elimination can take up to 5 months in some patients, and monitoring for side effects should continue throughout that window.
Half-Life and Full Elimination
The terminal half-life of Simponi is approximately 12 days (plus or minus 3 days) in healthy people, with similar values in patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, or ulcerative colitis. A drug’s half-life is the time it takes for half of it to leave your bloodstream. After one half-life (about 12 days), half the drug remains. After two half-lives (about 24 days), a quarter remains, and so on.
Pharmacologists generally consider a drug eliminated after 4 to 5 half-lives. For Simponi, that works out to roughly 48 to 84 days, or about 7 to 12 weeks. But this is an average. In patients with rheumatoid arthritis, the measured half-life ranged from 12 to 24 days, which means some people could take considerably longer to clear the drug. At the upper end of that range, full elimination could stretch past 4 months.
Why Clearance Time Varies
Not everyone eliminates Simponi at the same rate. Clinical pharmacology data from the FDA show that the half-life in healthy volunteers was 11 to 13 days, while in rheumatoid arthritis patients it ranged from 12 to 24 days. Several factors explain this spread.
Body weight plays a role because Simponi is a large protein molecule (a monoclonal antibody), and larger people have a bigger volume for the drug to distribute through. Disease activity also matters: active inflammation can alter how quickly your body breaks down and clears antibody-based drugs. The development of anti-drug antibodies, where your immune system produces its own antibodies against Simponi, can speed up clearance in some patients.
Simponi Before Surgery
If you’re planning surgery, your medical team will likely want Simponi out of your system (or at least significantly reduced) to lower infection risk. UK perioperative guidelines recommend scheduling surgery so that you miss at least one dose, meaning a minimum of 29 days after your last injection of the standard monthly formulation. For procedures that carry an especially high infection risk, the recommendation is to stop 3 to 5 half-lives before surgery, which translates to roughly 6 to 10 weeks.
These timelines are worth discussing with both your rheumatologist and your surgeon well in advance, since they need to balance infection risk against the possibility of a disease flare if you go too long without treatment.
How Long Side Effects Can Linger
Because Simponi suppresses part of your immune system (specifically, it blocks a protein called TNF-alpha that drives inflammation), its immunosuppressive effects persist as long as meaningful levels of the drug remain in your blood. That means your infection risk stays elevated for weeks after your final dose, not just days. The European Medicines Agency recommends continued monitoring for up to 5 months after the last injection, reflecting the outer boundary of how long the drug’s effects can linger.
Common side effects like injection site reactions will resolve quickly once you stop. But the increased susceptibility to infections, which is the primary safety concern with all TNF blockers, tracks closely with how long the drug remains detectable.
Pregnancy and Newborn Exposure
Simponi crosses the placenta, particularly during the third trimester, which is a characteristic shared by all monoclonal antibodies. The drug has been detected in fetal blood as early as the end of the second trimester and can remain in a newborn’s bloodstream for up to 6 months after birth. Because of this prolonged presence, live vaccines (such as the rotavirus vaccine) are not recommended for infants exposed to Simponi in the womb until at least 6 months after the mother’s last dose.
If you’re pregnant or planning a pregnancy, the timing of your last Simponi dose matters significantly for your baby’s vaccination schedule and infection risk in those early months.
Quick Reference: Estimated Clearance Timeline
- 2 weeks after last dose: Roughly half the drug remains
- 4 weeks: About 25% remains
- 6 to 8 weeks: Low but still potentially active levels
- 10 to 12 weeks: Cleared in most patients
- Up to 5 months: Upper limit for complete elimination in slower metabolizers